- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on IDH1-mutant Cholangiocarcinoma in United States
Total 443 results
-
National Cancer Institute (NCI)RecruitingIntrahepatic CholangiocarcinomaUnited States
-
NRG OncologyNational Cancer Institute (NCI)TerminatedStage III Intrahepatic Cholangiocarcinoma | Stage IVA Intrahepatic CholangiocarcinomaUnited States, Canada
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Mixed Hepatocellular CholangiocarcinomaUnited States, Italy
-
Jasper GerritsenMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Brain Neoplasms | Astrocytoma, Grade III | High-grade Glioma | Astrocytoma, Grade IV | Glioblastoma, IDH-mutant | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Brain Neoplasm, Primary | Brain Neoplasm, Malignant | Astrocytoma, Malignant | Brain Neoplasms, AdultUnited States, Germany, Belgium, Switzerland, Netherlands
-
Ronald DeMatteo, M.D.RecruitingIntrahepatic Cholangiocarcinoma | Colorectal Cancer Metastatic to LiverUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingIntrahepatic CholangiocarcinomaChina, United States
-
National Cancer Institute (NCI)RecruitingCholangiocarcinoma | Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Gallbladder Carcinoma | Stage III Gallbladder Cancer AJCC v8 | Stage III Hilar Cholangiocarcinoma AJCC v8 | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Hilar Cholangiocarcinoma AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma...United States
-
Memorial Sloan Kettering Cancer CenterRecruitingIntrahepatic CholangiocarcinomaUnited States
-
University of UtahTerminatedPrimary Myelofibrosis | Anemia | Thrombocytopenia | Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | IDH2 Gene Mutation | IDH1 Gene Mutation | Secondary Myelofibrosis | ASXL1 Gene Mutation | EZH2 Gene MutationUnited States
-
Florida Hospital Tampa Bay DivisionEnrolling by invitationHepatocellular Carcinoma | Liver Tumor | Hilar Cholangiocarcinoma | Liver CancerUnited States
-
Sirtex MedicalCompletedIntrahepatic CholangiocarcinomaFrance, United Kingdom, Belgium, Australia, Spain, United States, Italy, Netherlands
-
Incyte CorporationRecruitingMetastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States, Canada, Belgium, France, Germany, Italy, China, Spain, Japan, United Kingdom, Netherlands, Switzerland, Austria, Denmark, Finland, Ireland, Israel, Norway, Sweden
-
Massachusetts General HospitalExelixisCompletedBile Duct Cancer | Intrahepatic Cholangiocarcinoma | Cholangiocarcinoma of the Extrahepatic Bile DuctUnited States
-
Concordia Laboratories Inc.TerminatedHilar CholangiocarcinomaUnited States, Korea, Republic of, Canada, Switzerland, Germany
-
Jason J. Luke, MDBristol-Myers Squibb; Agios Pharmaceuticals, Inc.CompletedGlioma | Advanced Solid Tumor | IDH1 MutationUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI); Syndax PharmaceuticalsCompletedPancreatic Cancer | Cholangiocarcinoma | Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer | Metastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States
-
Weill Medical College of Cornell UniversityUnknownBiliary Stricture | Unresectable Cholangiocarcinoma | Biliary Obstruction | Stent ObstructionUnited States
-
Washington University School of MedicineCompletedCarcinoma, Hepatocellular | Intrahepatic CholangiocarcinomaUnited States
-
University of California, San FranciscoBeiGene USA, Inc.; Pacific Pediatric Neuro-Oncology ConsortiumRecruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent WHO Grade III Glioma | WHO Grade III Glioma | IDH2 Gene Mutation | IDH1 Gene Mutation | Low Grade Glioma | Recurrent WHO Grade II Glioma | WHO Grade II GliomaUnited States
-
University of WashingtonCompleted
-
National Cancer Institute (NCI)CompletedEpithelioid Mesothelioma | Cholangiocarcinoma, Extrahepatic | Neoplasms With Mesothelin Expression | Adenocarcinoma, PancreaticUnited States
-
Basilea PharmaceuticaArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedSolid TumorUnited States, Italy
-
Taiho Oncology, Inc.Approved for marketingAdvanced CholangiocarcinomaUnited States
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedUnresectable Extrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Stage IIIA Gallbladder Cancer AJCC v7 | Stage IIIB Gallbladder Cancer AJCC v7 | Stage IVA Gallbladder Cancer AJCC v7 | Stage IVB Gallbladder Cancer AJCC v7 | Stage III Intrahepatic Cholangiocarcinoma AJCC v7 | Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCholangiocarcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Stage III Gallbladder Cancer AJCC v7 | Stage IIIA Gallbladder Cancer AJCC v7 | Stage IIIB Gallbladder Cancer AJCC v7 | Stage IV Gallbladder Cancer AJCC v7 | Stage IVA Gallbladder Cancer AJCC v7 | Stage... and other conditionsUnited States
-
Kura Oncology, Inc.CompletedThyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant TumorSpain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
-
D. Kim Turgeon, MDUniversity of WashingtonCompleted
-
Weill Medical College of Cornell UniversityTerminatedCholangiocarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable Hepatocellular Carcinoma | Metastatic Cholangiocarcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular... and other conditionsUnited States
-
Virogin Biotech Canada LtdRecruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
National Cancer Institute (NCI)SuspendedMalignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Refractory CholangiocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedEGFR-Mutant Lung CancerUnited States
-
University of California, San FranciscoParker Institute for Cancer Immunotherapy; The V Foundation; Alliance for Cancer...RecruitingDiffuse Midline Glioma, H3 K27M-MutantUnited States
-
Basilea PharmaceuticaCompletedIntrahepatic Cholangiocarcinoma | Combined Hepatocellular and CholangiocarcinomaCanada, United States, Spain, Belgium, Italy, Korea, Republic of, Germany, Switzerland, France, United Kingdom, Ireland
-
Memorial Sloan Kettering Cancer CenterAgios Pharmaceuticals, Inc.RecruitingChondrosarcoma | IDH1 Gene Mutation | Chondrosarcoma, Grade 2 | Chondrosarcoma, Grade 3United States
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Jonsson Comprehensive Cancer CenterNot yet recruitingDiffuse Hemispheric Glioma, H3 G34-MutantUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingDiffuse Midline Glioma, H3 K27M-MutantUnited States
-
EpicentRx, Inc.TerminatedCholangiocarcinomaUnited States
-
University of Alabama at BirminghamSociety of Abdominal RadiologyCompletedCholangiocarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBTG International Inc.CompletedCholangiocarcinomaUnited States
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
Washington University School of MedicineTerminatedCholangiocarcinomaUnited States
-
Danielle Kim TurgeonTerminated
-
National Cancer Institute (NCI)RecruitingColorectal Neoplasms | Colorectal Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bile Duct Neoplasms | Metastatic Colorectal Cancer (Mcrc) | Intrahepatic Cholangiocarcinoma (Icc) | Intrahepatic Bile Duct CancerUnited States
-
TriSalus Life Sciences, Inc.Active, not recruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
University of New MexicoTerminatedCholangiocarcinomaUnited States
-
Methodist Health SystemEnrolling by invitationMetastatic Cancer | Intrahepatic Cholangiocarcinoma | Liver Tumor | Metastatic Liver CancerUnited States
-
Roswell Park Cancer InstituteGenentech, Inc.CompletedCholangiocarcinomaUnited States